Skip to main content
Top
Published in: Critical Care 1/2015

Open Access 01-12-2015 | Poster presentation

Clinical experience of using a novel extracorporeal cytokine adsorption column for treatment of septic shock with multiorgan failure

Authors: P Sathe, P Sakhavalkar, S Kumar, S Choudhary

Published in: Critical Care | Special Issue 1/2015

Login to get access

Excerpt

Severe sepsis and multiorgan failure (MOF) are major causes of death in the ICU. The extracorporeal cytokine adsorption column (ECAC; Cytosorb®, CytoSorbents Corporation, USA), a critical care focused therapeutic device, results in rapid in vitro and in vivo elimination of several key cytokines and prevents organ failure. Use of ECAC in patients with sepsis is a new area of research with insufficient data to promote large prospective RCTs. Studies published to date have shown promising results. We report our clinical experience with ECAC for severe sepsis/septic shock/MOF patients. …
Metadata
Title
Clinical experience of using a novel extracorporeal cytokine adsorption column for treatment of septic shock with multiorgan failure
Authors
P Sathe
P Sakhavalkar
S Kumar
S Choudhary
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 1/2015
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc14210

Other articles of this Special Issue 1/2015

Critical Care 1/2015 Go to the issue